Please read and agree to the terms and conditions of this site.
@xconomy.com 4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com 4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com 4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com 5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com 5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com 5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com 5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@Primary_Immune1 7 years ago
Disabling #Hemophilia to 'Normal Life' After 1-Dose #GeneTherapy | https://www.eurekalert.org/pub_releases/2016-12/chop-agt120116.php #SNRTG #BigData… https://twitter.com/i/web/status/805757557679722496
@extremetech.com 7 years ago
Hemophilia ‘cures’ are proving gene therapy really is all it’s cracked up to be